Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1994-03-15
1996-12-03
Gupta, Yogendra N.
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
540505, 540510, 540511, 540542, 540569, 540570, 540571, 540572, C07D24316, C07D24320, C07D24322
Patent
active
055809790
ABSTRACT:
The present invention makes available novel compounds represented by the general formula ##STR1## wherein Y represents a phosphate analog. Which compounds are useful for inhibiting an interaction between a protein containing an SH2 domain and a phophotyrosine-containing polypeptide.
REFERENCES:
patent: 4424226 (1984-01-01), Eberlein et al.
patent: 4594191 (1986-06-01), Bock et al.
patent: 4628084 (1986-12-01), Bock et al.
patent: 4650797 (1987-03-01), Atwal
patent: 4755508 (1988-07-01), Bock et al.
patent: 4820834 (1989-04-01), Evans et al.
patent: 4898861 (1990-02-01), Morgan et al.
patent: 4957915 (1990-09-01), Kim et al.
patent: 5116971 (1992-05-01), Harreus et al.
patent: 5175159 (1992-12-01), Bock et al.
Science, vol. 260, 1937-1942, 1993.
James, G. L., et al., (1993), "Benzodiazepine Peptoidomimetics: Potent Inhibitors of Ras Farnesylation in Animal Cells", Science, vol. 260, pp. 1937-1942.
Eck, M. J., et al., (1993), "Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56.sup.lck ", Nature, vol. 362, pp. 87-91.
Waksman, G., et al., (1993), "Binding of a High Affinity Phosphotyrosyl Peptide to the Src SH2 Domain: Crystal Structures of the Complexed and Peptide-free Forms", Cell, vol. 72, pp. 779-790.
Songyang, Z., et al., (1993), "SH2 Domains Recognize Specific Phosphopeptide Sequences", Cell, vol. 72, pp. 767-778.
Sierke, S. L., and Koland, J. G., (1993), "SH2 Domain Proteins as High-Affinity Receptor Tyrosine Kinase Substrates", Biochemistry, vol. 32, pp. 10102-10108.
Pawson, T. and Gish, G. D., (1992), "SH2 and SH3 Domains: From Structure fo Function", Cell, vol. 71, pp. 359-362.
Birge, R. B., et al., (1992), "Tyrosine-phosphorylated Epidermal Growth Factor Receptor and Cellular p130 Provide High Affinity Binding Substrates to Analyze Crk-Phosphotyrosine-dependent Interactions in Virto", The Journal of Biological Chemistry, vol. 267, No. 16, pp. 10588-10595.
Petsko, G. A., (1992), "Fishing in Src-infested waters", Nature, vol. 358, pp. 625-626.
Fanti, W. J., et al., (1992), "Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways", Cell, vol. 69, pp. 413-423.
Domchek, S. M., et al., (1992), "Inhibition of SH2 Domain/Phosphoprotein Association by a Nonhydrolyzable Phosphonopeptide", Biochemistry, vol. 31, pp. 9865-9870.
Pendergast, A. M., et al., (1993), "BCR-ABL-Induced Oncogenesis is Mediated by Direct Interaction with the SH2 Domain of the GRB-2 Adaptor Protein", Cell, vol. 75, pp. 175-185.
Schlessinger, J., (1993), "How receptor tyrosine kinases activates Ras", Trends Biochem. Sci., vol. 18, pp. 273-275.
Tsukada, S., et al., (1993), "Deficient Expression of a B Cell Cytoplasmic Tyrosine Kinase in Human X-Linked Agammaglobulinemia", Cell, vol. 72, pp. 279-290.
Ahmad, S., (1993), "A widely expressed human protein-tyrosine phosphatase containing src homology 2 domain", Proceedings of the National Academy of Sciences, vol. 90, pp. 2197-2201.
David, M., et al., (1993), "In Vitro Activation of the Transcription Factor ISGF3 by Interferon .alpha. Involves a Membrane-associated Tyrosine Phosphatase and Tyrosine Kinase", The Journal of Biological Chemistry, vol. 268, No. 9, pp. 6593-6599.
Igarshi, K., et al., (1993), "In Vitro Activation of the Transcription Factor Gamma Interferon Activation Factor by Gamma Interferon: Evidence for a Tyrosine Phosphatase/Kinase Signaling Cascade", Molecular and Cellular Biology, vol. 13, No. 3, pp. 1634-1640.
Feig, L. A., (1993), "The Many Roads That Lead to Ras", Science, vol. 260, pp. 767-768.
Rudd, C. E., et al. (1993), "src-related protein tyrosine kinases and their surface receptors", Biochimica et Biophysica Acta, vol. 1155, pp. 239-266.
Cambier, J. C. and Cambell, K. S., (1992), "Membrane immunoglobulin and its accomplices: new lessons from an old receptor", The FASEB Journal, vol. 6, pp. 3207-3217.
Cantley, L. C., et al., (1991), "Oncogenes and Signal Transduction", Cell, vol. 64, pp. 281-302.
Evans, B. E., et al., (1988), "Methods for Drug Discovery: Development of Potent, Selective, Orally Effective Cholecystokinin Antagonists", J. Med. Chem., vol. 31, pp. 2235-2246.
Bock, M. G., et al., (1987), "An Expedient Synthesis of 3-Amino-1, 3-Dihydro-5-Phenyl-2H-1, 4-Benzodiazepin-2-One", Tetrahedron Letters, vol. 28, No. 9, pp. 939-942.
Evans, B. E., et al., (1987), "Design of Non peptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists", J. Med. Chem., vol. 30, pp. 1229-1239.
Bock, M. G., et al., (1987), "Synthesis and Resolution of 3-Amino-1, 3-Dihydro-5-Phenyl-2H-1, 4-Benzodiazepin-2-ones", J. Org. Chem., vol. 52, pp. 3232-3239.
Chang, R. S. L. and Lotti, V. J., (1986), "Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist", Proceedings of the National Academy of Sciences, vol. 83, pp. 4923-4926.
Hirai, K., et al., (1980), "Peptidoaminobenzophenones, a Novel Class of Ring-Opened Derivatives of 1,4-Benzodiazephines", J. Med. Chem., vol. 23, pp. 764-773.
Freidinger, R. M., (1987), "Design and comparison of nonpeptide and peptide CCK antagonists", Peptides Chemistry and Biology Proceedings of the Tenth American Peptide Symposium, May 23-28, pp. 97-100.
DeConti, Jr. Giulio A.
Gupta Yogendra N.
Trustees of Tufts University
Vincent Matthew P.
LandOfFree
Phosphotyrosine peptidomimetics for inhibiting SH2 domain intera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphotyrosine peptidomimetics for inhibiting SH2 domain intera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphotyrosine peptidomimetics for inhibiting SH2 domain intera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-786561